Journal
BIOLOGICAL RESEARCH
Volume 45, Issue 3, Pages 269-277Publisher
SOC BIOLGIA CHILE
DOI: 10.4067/S0716-97602012000300008
Keywords
Mesenchymal stem cells; autoimmune diseases; cellular therapy
Categories
Funding
- Universidad de los Andes [MED-004-7, MED 002/09]
- lnnova Chile Corfo [205-4350]
Ask authors/readers for more resources
Mesenchymal stem cells (MSCs) are now known to display not only stem cell multipotency, but also robust antiinflammatory and regenerative properties. After widespread in-vitro and in-vivo preclinical testing, autologous and allogeneic MSCs have been applied in a range of immune mediated conditions, including graft versus host disease, Crohn's disease, multiple sclerosis, refractory systemic lupus erythematosus and systemic sclerosis. Current data suggests that MSCs may not only replace diseased tissues, but also exert several trophic, regenerative and antiinflarnmatory effects. While the clinical outcome in case reports and phase trials seems occasionally striking, these limited results point to the need to perform controlled multicenter trials. Future advances from stem cell science can be expected to pinpoint significant MSC subpopulations and/or stem cell markers for improved regenerative or immunoregulatory properties.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available